A Retrospective Study of Treatment Patterns and Clinical Outcomes in Patients With Central Nervous System Tuberculosis
Study Details
Study Description
Brief Summary
This is a retrospective clinical study to analyze the clinical characteristics, complications, and effects of different treatment options on long-term prognosis in patients with central nervous system tuberculosis. All cases of central nervous system tuberculosis diagnosed between 2016 and 2021 were included in the electronic medical record system of one center, and data such as demographics, hospitalization information, clinical information, laboratory or imaging examinations, treatment plans, and outcomes were collected.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
|
Study Design
Outcome Measures
Primary Outcome Measures
- 2-year survival rate [1 years,2 years]
Calculate the 1-year survival rate and 2-year survival rate.
- 2-year disability rate [1 years,2 years]
Calculate the 1-year disability rate and 2-year disability rate. Common disabilities include aphasia, hemiplegia, paraplegia, deafness, blindness, mental retardation, etc. For reference, please refer to the 《Grading of Human Injury and Disability Degree》 and 《Guidance for determination of cause-and-effect relationship between personal injury and disease》.
Secondary Outcome Measures
- Clinical features: age of onset, mode of onset [2 years]
age of onset, mode of onset
- The presense of clinical symptoms of patients [2 years]
The number and severity of clinical symptoms of patients.
- Incidence of complications in patients with different treatment regimens [2 years]
The electronic medical record system was used to collect patients' complications from baseline (admission) to 24 months, and the incidence of complications of different treatment options was compared.
- length of hospital stay [2 years]
- proportion of patients admitted to ICU [2 years]
Eligibility Criteria
Criteria
Inclusion Criteria:
- The patient meets the following criteria 1) or 2) or 3):
-
The discharge diagnosis is central nervous system tuberculosis, refer to the ICD-10 code related to central nervous system tuberculosis.
-
The discharge diagnosis was tuberculous meningitis (ICD-10: A17.000), or tuberculous cerebrospinal meningitis (ICD-10: A17.001), or tuberculous meningoencephalitis (ICD-10: A17.803 ), or tuberculous encephalitis (ICD-10: A17.804), or tuberculous brain abscess (ICD-10: A17.805), or spinal tuberculosis (ICD-10: A17.806), or tuberculous encephalitis Water (ICD-10: A17.807).
-
Tuberculous meningitis diagnosed according to the "Guidelines for Diagnosis and Treatment of Central Nervous System Tuberculosis in China (2019 Edition)"
- Age and gender are not limited.
Exclusion Criteria:
-
Patients with no clear diagnosis at discharge.
-
Patients judged by the investigator to be unsuitable for inclusion in this protocol.
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology | Wuhan | Hubei | China | 430030 |
| 2 | Wuhan Pulmonary Hospital(Wuhan Institute for Tuberculosis Control) | Hubei | Wuhan | China | 430030 |
Sponsors and Collaborators
- Tongji Hospital
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- RETUBO-N